Showing 2771-2780 of 4012 results for "".
- Understanding the Complexities of Small Cell Lung Cancerhttps://reachmd.com/news/understanding-the-complexities-of-small-cell-lung-cancer/2471008/What's New Small cell lung cancer (SCLC), a swift and aggressive disease, continues to challenge healthcare providers and researchers alike. As understanding of its characteristics and treatment strategies evolve, clinicians stand at the forefront of integrating inn
- Heart Transplant Patients Show Increased Skin Cancer Incidence: Meta-Analysishttps://reachmd.com/news/heart-transplant-patients-show-increased-skin-cancer-incidence-meta-analysis/2470902/Heart transplant (HTx) recipients face a 16% overall risk of developing skin cancer, with squamous and basal cell carcinomas being the most common forms, a new meta-analysis indicated. "Studies have shown that patients who undergo HTx are at an increased risk for developing skin cancer," t
- Navigating Cytomegalovirus Risks in Immunocompromised ICU Patientshttps://reachmd.com/news/navigating-cytomegalovirus-risks-immunocompromised-icu-patients/2470866/What's New Cytomegalovirus (CMV) infection is a formidable challenge for critically ill, immunocompromised patients in intensive care units. Recent insights into its management are crucial for improving patient outcomes. Significance Healthcare profe
- Neighborhood Disadvantage Linked to Higher Blood Pressure and Cognitive Declinehttps://reachmd.com/news/neighborhood-disadvantage-linked-to-higher-blood-pressure-and-cognitive-decline/2470824/Living in a disadvantaged neighborhood may negatively affect both physical and cognitive health, even in individuals without a diagnosis of mild cognitive impairment (MCI), according to new research from Wake Forest University School of Medicine. Published in Alzheimer’s & Dementia: Diagn
- Elevai Skincare Inc. Acquired by Bio-Aesthetics Company Carmellhttps://reachmd.com/news/elevai-skincare-inc-acquired-by-bio-aesthetics-company-carmell/2473723/Carmell Corporation, a bio-aesthetics company focused on skin and hair health, announced in a press release that it entered into a definitive purchase agreement with PMGC Holdings Inc. (formerly Elevai Labs Inc.) and its wholly owned subsidiary, Elevai Skincare Inc., to acquire the assets related
- ESC Highlights Growing Need for Cardio-Oncology at Inaugural 2025 Conferencehttps://reachmd.com/news/esc-highlights-growing-need-for-cardio-oncology-at-inaugural-2025-conference/2470797/Cardiovascular health is gaining greater attention in cancer care as the European Society of Cardiology (ESC) prepares to host its first-ever cardio-oncology conference. Scheduled for June 20–21, 2025, in Florence, Italy, this global forum will bring together experts to address the overlap betwee
- Microplastics in the Air May Be Leading to Lung and Colon Cancershttps://reachmd.com/news/microplastics-in-the-air-may-be-leading-to-lung-and-colon-cancers/2470796/Tires and degrading garbage shed tiny pieces of plastic into the air, creating a form of air pollution that UC San Francisco researchers suspect may be causing respiratory and other illnesses. A review of some 3,000 studies implicates these particles in a variety of serious hea
- Evaluating Ventilation Strategies During Extubation for Surgical Patientshttps://reachmd.com/news/evaluating-ventilation-strategies-during-extubation-surgical-patients/2470784/What's New A new study sheds light on the potential risks associated with clot formation in the clearing fluid used after blood sampling via arterial catheters in intensive care settings. Significance Understanding these risks is crucial for improving patie
- Targeting Brain Enzymes to Combat Obesity: A New Frontier in Weight Controlhttps://reachmd.com/news/targeting-brain-enzymes-to-combat-obesity-a-new-frontier-in-weight-control/2470674/The fight against obesity has taken a step forward with new research highlighting how the brain’s endocannabinoid system influences food intake and physical activity. A team of researchers at the Université de Montréal’s CRCHUM has discovered that modulating a specific brain enzyme could help cur
- Preclinical Study Explores mRNA-Based Treatment for Proliferative Vitreoretinopathyhttps://reachmd.com/news/preclinical-study-explores-mrna-based-treatment-for-proliferative-vitreoretinopathy/2470685/A preclinical study from Mass Eye and Ear offers hope for patients at risk of blindness caused by proliferative vitreoretinopathy (PVR), a severe complication of retinal detachment or eye trauma. PVR occurs when scar tissue forms inside the eye, detaching the retina and impairing vision. The nove